Literature DB >> 22811818

Low risk of prevalent submucosal invasive cancer among patients undergoing esophagectomy for treatment of Barrett's esophagus with high grade dysplasia.

Vani Ja Konda1, Irving Waxman.   

Abstract

Entities:  

Year:  2011        PMID： 22811818      PMCID： PMC3397593          DOI： 10.3978/j.issn.2078-6891.2011.005

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  34 in total

Review 1.  Pro: esophagectomy is the treatment of choice for high-grade dysplasia in Barrett's esophagus.

Authors:  Thomas W Rice
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

2.  Predictive factors of coexisting cancer in Barrett's high-grade dysplasia.

Authors:  C Tharavej; J A Hagen; J H Peters; G Portale; J Lipham; S R DeMeester; C G Bremner; T R DeMeester
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

3.  Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists.

Authors:  M Kerkhof; H van Dekken; E W Steyerberg; G A Meijer; A H Mulder; A de Bruïne; A Driessen; F J ten Kate; J G Kusters; E J Kuipers; P D Siersema
Journal:  Histopathology       Date:  2007-06       Impact factor: 5.087

4.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus.

Authors:  B J Reid; R C Haggitt; C E Rubin; G Roth; C M Surawicz; G Van Belle; K Lewin; W M Weinstein; D A Antonioli; H Goldman
Journal:  Hum Pathol       Date:  1988-02       Impact factor: 3.466

5.  Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy.

Authors:  J J Nigro; J A Hagen; T R DeMeester; S R DeMeester; J Theisen; J H Peters; M Kiyabu
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

6.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia.

Authors:  T G Schnell; S J Sontag; G Chejfec; G Aranha; A Metz; S O'Connell; U J Seidel; A Sonnenberg
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

7.  Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus.

Authors:  Femke P Peters; Klasina P M Brakenhoff; Wouter L Curvers; Wilda D Rosmolen; Paul Fockens; Fiebo J W ten Kate; Kausilia K Krishnadath; Jacques J G H M Bergman
Journal:  Gastrointest Endosc       Date:  2007-12-26       Impact factor: 9.427

8.  Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases.

Authors:  F Paraf; J F Fléjou; J P Pignon; F Fékété; F Potet
Journal:  Am J Surg Pathol       Date:  1995-02       Impact factor: 6.394

9.  An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.

Authors:  D S Levine; R C Haggitt; P L Blount; P S Rabinovitch; V W Rusch; B J Reid
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682

10.  Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma.

Authors:  C V Lopes; M Hela; C Pesenti; E Bories; F Caillol; G Monges; M Giovannini
Journal:  Surg Endosc       Date:  2007-02-09       Impact factor: 3.453
View more
  1 in total

1.  A Multiscale Model Evaluates Screening for Neoplasia in Barrett's Esophagus.

Authors:  Kit Curtius; William D Hazelton; Jihyoun Jeon; E Georg Luebeck
Journal:  PLoS Comput Biol       Date:  2015-05-22       Impact factor: 4.475
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.